LH Laboratory Corp Of America Holdings

  1. Stocks
  2. Healthcare
  3. NYSE: LH

Price (delayed)

$259.83

Market cap

$21.31B

P/E Ratio

22.87

Dividend/share

$2.88

EPS

$11.36

Enterprise value

$27.57B

?
Relative Growth: Rel. Growth: 61
Relative Strength: Rel. Strength: 34
Relative Valuation: Rel. Valuation: 73
Relative Profitability: Rel. Profitability: 61

Laboratory Corporation of America Holdings, more commonly known as LabCorp, is an American S&P 500 company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks ...

Highlights
The quick ratio has grown by 31% from the previous quarter
Laboratory Corp Of America Holdings's EPS has increased by 30% YoY and by 8% QoQ
The debt has increased by 11% year-on-year and by 11% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.labcorp.com
Peers: DGX NEO QGEN IDXX

Key stats

What are the main financial stats of LH

LH stock price

How has the Laboratory Corp Of America Holdings stock price performed over time
Intraday
2.12%
1 week
-1.86%
1 month
-0.04%
1 year
-0.46%
YTD
3.57%
QTD
-2.62%

Financial performance

How have Laboratory Corp Of America Holdings's revenue and profit performed over time
Revenue
$14.14B
Gross profit
$4.08B
Operating income
$1.44B
Net income
$941.5M
Gross margin
28.8%
Net margin
6.7%
Laboratory Corp Of America Holdings's operating income has increased by 32% YoY and by 4% QoQ
LH's net income is up by 29% YoY and by 7% from the previous quarter
The operating margin has grown by 23% YoY and by 3% from the previous quarter
The net margin has increased by 22% year-on-year and by 6% since the previous quarter

Price vs fundamentals

How does LH's price correlate with its fundamentals

Growth

What is Laboratory Corp Of America Holdings's growth rate over time

Valuation

What is Laboratory Corp Of America Holdings stock price valuation
LH P/E details
P/E
22.87
P/B
2.45
P/S
1.51
EV/EBIT
20.06
EV/EBITDA
12.15
EV/Sales
1.95
Laboratory Corp Of America Holdings's EPS has increased by 30% YoY and by 8% QoQ
The price to earnings (P/E) is 14% lower than the last 4 quarters average of 26.0 and 7% lower than the 5-year quarterly average of 24.1
The P/B is 8% lower than the last 4 quarters average of 2.6
The company's equity rose by 5% YoY
LH's price to sales (P/S) is 13% lower than its 5-year quarterly average of 1.7 and 8% lower than its last 4 quarters average of 1.6
LH's revenue is up by 7% year-on-year

Efficiency

How efficient is Laboratory Corp Of America Holdings business performance
LH's ROA is up by 24% YoY and by 6% QoQ
LH's ROE is up by 21% YoY and by 6% QoQ
The company's return on invested capital rose by 11% YoY and by 2.6% QoQ
Laboratory Corp Of America Holdings's return on sales has increased by 10% YoY and by 2.1% QoQ

Dividends

What is LH's dividend history
Dividend details
DPS
$2.88
Dividend yield
1.11%
Payout ratio
25.4%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Laboratory Corp Of America Holdings financials performed over time
LH's total assets is 85% greater than its total liabilities
The quick ratio has grown by 31% from the previous quarter
Laboratory Corp Of America Holdings's current ratio has increased by 22% from the previous quarter but it has decreased by 6% YoY
The debt is 17% smaller than the equity
The debt has increased by 11% year-on-year and by 11% since the previous quarter
LH's debt to equity is up by 9% since the previous quarter and by 6% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.